Principles of CRISPR-Cas13 mismatch intolerance enable selective silencing of point-mutated oncogenic RNA with single-base precision.
Journal: Science advances
Year: December 18, 2024
Hematologist-Oncologist
5
No OPD information available
Anemia
B-Cell Lymphoma
Malignant Hypertension
Multiple Myeloma
Myelodysplastic Syndrome (MDS)
Non-Hodgkin Lymphoma
Peripheral T-Cell Lymphoma
Acute Myeloid Leukemia (AML)
Acute Promyelocytic Leukemia
Adult Immune Thrombocytopenia
Agranulocytosis
Autoimmune Hemolytic Anemia
Blood Clots
Bone Marrow Transplant
Chronic Myelogenous Leukemia (CML)
D-Minus Hemolytic Uremic Syndrome
D-Plus Hemolytic Uremic Syndrome
Diffuse Large B-Cell Lymphoma (DLBCL)
Essential Thrombocythemia
Follicular Lymphoma
Ganglioneuroma
Hemolytic Anemia
Hemolytic-Uremic Syndrome
High Potassium Level
Immune Thrombocytopenic Purpura (ITP)
Leukemia
Leukocytosis
Marginal Zone Lymphoma (MZL)
Myelofibrosis
Pleural Effusion
Purpura
Severe Acute Respiratory Syndrome (SARS)
Sezary Syndrome
T-Cell Lymphoma
Thrombocytopenia
X-Linked Lymphoproliferative Disease
Jake Shortt is a male healthcare provider who helps people with different blood and cancer problems. Some of the conditions he treats include anemia, leukemia, lymphoma, and blood clotting issues. He also does bone marrow transplants to help patients get better.
Jake Shortt is very good at talking to patients and making them feel comfortable. He listens to their concerns and explains things in a way they can understand. Patients trust him because he is kind, caring, and knowledgeable about their health problems.
To stay updated with the latest medical information, Jake Shortt reads scientific studies and attends conferences. This helps him provide the best care for his patients. He also works with other doctors and nurses to share knowledge and learn from each other.
Jake Shortt has written a research paper called "Principles of CRISPR-Cas13 mismatch intolerance enable selective silencing of point-mutated oncogenic RNA with single-base precision." This paper helps other doctors understand how to treat cancer more effectively. He is also involved in a clinical trial to test a new treatment for a type of blood disorder.
Jake Shortt's work has made a positive impact on many patients' lives. By treating their illnesses and providing support, he helps them feel better and live healthier lives. His dedication to his patients and his commitment to learning and improving healthcare make him a valuable member of the medical community.
Journal: Science advances
Year: December 18, 2024
Enrollment Status: Active not recruiting
Published: October 28, 2024
Intervention Type: Drug
Study Drug:
Study Phase: Phase 3
Jake Shortt is an amazing Hematologist-Oncologist. He is very caring and knowledgeable. I felt safe and well taken care of during my treatment.
Dr. Jake Shortt is a top-notch Hematologist-Oncologist. He explained everything clearly and made me feel comfortable throughout my appointments. Highly recommend!
I had a great experience with Dr. Jake Shortt as my Hematologist-Oncologist. He is compassionate and skilled in his field. I am grateful for his care.
Dr. Jake Shortt is a fantastic Hematologist-Oncologist. He is attentive and thorough in his approach. I trust him completely with my treatment.
I highly recommend Dr. Jake Shortt as a Hematologist-Oncologist. He is kind, understanding, and truly dedicated to his patients' well-being. Thank you for your excellent care!
Dr. Jake Shortt is an exceptional Hematologist-Oncologist. He is not only knowledgeable but also very supportive. I am grateful to have him as my doctor.
My experience with Dr. Jake Shortt as my Hematologist-Oncologist was outstanding. He is professional, caring, and always goes above and beyond for his patients. Thank you for everything!